Solas-Lung

_SOLAS-RONG_加强了Beamline和伦敦大学学院(UCL)之间的合作伙伴关系，主要项目旨在完成开发我们的技术获得监管批准所需的400名患者的首个临床试验：将_SOLAS-RONG_推进到TRL6/7\。伦敦大学学院拥有10年开创性的研究成果，支持癌细胞的红外检测。他们是SOLAS-LONG进入下一阶段的理想临床合作伙伴，并与世界领先的研究人员相辅相成，打造一支全面的团队，确保项目成功。

_Solas-Lung_ reinforces a partnership between BeamLine and University College London (UCL) with the primary project aim to complete the 400 patient first in clinic trial required for developing our technology towards regulatory approval: advancing _Solas-Lung_ to TRL6/7\. UCL have supported IR detection of cancerous cells with \>10 years of ground-breaking research. They are the ideal clinical partner to progress _Solas-Lung_ to the next stage, and complement with world leading researchers, to produce a rounded team to ensure project success.